Targeting and inhibiting CMG2 (Capillary Morphogenesis Gene protein 2) represents a new strategy for therapeutic agents for cancer and retinal diseases due to CMG2's role in blood vessel growth (angiogenesis). A high throughput FRET (Förster Resonance Energy Transfer) assay was developed for the identification of CMG2 inhibitors as anti-angiogenetic agents. Bioassay-guided separation led to the isolation and identification of two new compounds (1 and 2) from CR252M, an endophytic fungus Coccomyces proteae collected from a Costa Rican rainforest, and one known compound (3) from CR1207B (Aurapex penicillata). Secondary in vitro assays indicated anti-angiogenic activity. Compound 3 inhibited the endothelial cell migration at 52 μM, but did not show any endothelial cell antiproliferative effect at 156 μM. The structure of the two new compounds, A (1) and B (2), were elucidated on the basis of extensive spectroscopic analysis, including 1D and 2D NMR experiments.
Targeting and inhibiting CMG2 (Capillary Morphogenesis Gene protein 2) represents a new strategy for therapeutic agents for cancer and pan class="Disease">retinal diseases due to CMG2's role in blood vessel growth (angiogenesis). A high throughput FRET (Förster Resonance Energy Transfer) assay was developed for the identification of CMG2 inhibitors as anti-angiogenetic agents. Bioassay-guided separation led to the isolation and identification of two new compounds (1 and 2) from CR252M, an endophytic fungus Coccomyces proteae collected from a Costa Rican rainforest, and one known compound (3) from CR1207B (Aurapex penicillata). Secondary in vitro assays indicated anti-angiogenic activity. Compound 3 inhibited the endothelial cell migration at 52 μM, but did not show any endothelial cell antiproliferative effect at 156 μM. The structure of the two new compounds, A (1) and B (2), were elucidated on the basis of extensive spectroscopic analysis, including 1D and 2D NMR experiments.
Authors: Michael S Rogers; Kenneth A Christensen; Amy E Birsner; Sarah M Short; Darran J Wigelsworth; R John Collier; Robert J D'Amato Journal: Cancer Res Date: 2007-10-15 Impact factor: 12.701
Authors: Darran J Wigelsworth; Bryan A Krantz; Kenneth A Christensen; D Borden Lacy; Stephen J Juris; R John Collier Journal: J Biol Chem Date: 2004-03-24 Impact factor: 5.157
Authors: Lorna M Cryan; Tsz-Ming Tsang; Jessica Stiles; Lauren Bazinet; Sai Lun Lee; Samuel Garrard; Erika Madrian; Cody Roberts; Jessie Payne; Andrew Jensen; Arthur E Frankel; P Christine Ackroyd; Kenneth A Christensen; Michael S Rogers Journal: Angiogenesis Date: 2022-02-25 Impact factor: 10.658
Authors: Chun-Shun Li; Ariel M Sarotti; Peng Huang; Uyen T Dang; Julian G Hurdle; Tamara P Kondratyuk; John M Pezzuto; James Turkson; Shugeng Cao Journal: Sci Rep Date: 2017-09-05 Impact factor: 4.379
Authors: Lorna M Cryan; Lauren Bazinet; Kaiane A Habeshian; Shugeng Cao; Jon Clardy; Kenneth A Christensen; Michael S Rogers Journal: J Med Chem Date: 2013-02-22 Impact factor: 8.039